Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field
- PMID: 2713210
- PMCID: PMC1379771
- DOI: 10.1111/j.1365-2125.1989.tb05342.x
Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field
Abstract
1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacological Society to ascertain facts about the administration of drugs to healthy volunteers over the period October 1986 to September 1987. 2. A response rate of 87.1% was obtained with 114 individuals being involved in healthy volunteer studies. After exclusion of duplicate returns from the same unit 98 questionnaires were analysed. 3. Drugs were given in the year under review to 8163 healthy volunteers for research purposes. Minor adverse effects were reported in 565 (6.9%), moderately severe adverse effects in 45 (0.55%) and potentially life threatening adverse effects in 3 (0.04%). No lasting sequelae were reported. 4. Drugs were given to 7607 healthy student volunteers as part of class teaching practicals. Minor adverse effects were reported in 6.0% of student exposures but no moderately severe or life threatening adverse effects were reported. 5. The risk involved in healthy volunteer studies is very small indeed but some suggestions are made as a result of the questionnaire to improve further the safety of these studies.
Similar articles
-
Adverse events in phase one studies: a study in 430 healthy volunteers.Eur J Clin Pharmacol. 1992;42(4):389-93. doi: 10.1007/BF00280124. Eur J Clin Pharmacol. 1992. PMID: 1516603
-
Compensation and drug trials.Br Med J (Clin Res Ed). 1983 Sep 3;287(6393):675-7. doi: 10.1136/bmj.287.6393.675. Br Med J (Clin Res Ed). 1983. PMID: 6411277 Free PMC article.
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Medication safety curriculum: enhancing skills and changing behaviors.BMC Med Educ. 2015 Dec 29;15:234. doi: 10.1186/s12909-015-0521-0. BMC Med Educ. 2015. PMID: 26711130 Free PMC article.
-
Phase I studies: what to measure?Fundam Clin Pharmacol. 1990;4 Suppl 2:59s-62s. doi: 10.1111/j.1472-8206.1990.tb00062.x. Fundam Clin Pharmacol. 1990. PMID: 2093638 Review.
Cited by
-
Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies.BMJ. 2015 Jun 26;350:h3271. doi: 10.1136/bmj.h3271. BMJ. 2015. PMID: 26115663 Free PMC article.
-
Payments to healthy volunteers--ethical problems.Br J Clin Pharmacol. 1991 Aug;32(2):141-2. doi: 10.1111/j.1365-2125.1991.tb03872.x. Br J Clin Pharmacol. 1991. PMID: 1931462 Free PMC article. No abstract available.
-
The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research.Br J Clin Pharmacol. 1999 Jul;48(1):25-31. doi: 10.1046/j.1365-2125.1999.00961.x. Br J Clin Pharmacol. 1999. PMID: 10383556 Free PMC article.
-
Risks of phase I research with healthy participants: A systematic review.Clin Trials. 2016 Apr;13(2):149-60. doi: 10.1177/1740774515602868. Epub 2015 Sep 8. Clin Trials. 2016. PMID: 26350571 Free PMC article.
-
Adverse events in phase one studies: a study in 430 healthy volunteers.Eur J Clin Pharmacol. 1992;42(4):389-93. doi: 10.1007/BF00280124. Eur J Clin Pharmacol. 1992. PMID: 1516603
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources